Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphisms.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples